U.S. Capital Markets Stock News

MoneyGram Haas F1 Team recently announced a new partnership with CSG Systems International, debuting their collaboration at the 2025 Formula 1 United States Grand Prix in Austin, Texas, to emphasize their shared commitment to innovation and performance. This partnership leverages the global exposure and fast-paced environment of Formula 1 racing to highlight CSG's expertise in empowering brands to engage customers and manage complexity. We'll now examine how CSG's new Formula 1 alliance...

Arcturus Therapeutics Holdings (ARCT) drew intense investor attention after it released interim results from a Phase 2 trial for its cystic fibrosis treatment, ARCT-032. The report showed no substantial lung function improvement, which triggered sharp share declines and analyst downgrades. See our latest analysis for Arcturus Therapeutics Holdings. It has been a turbulent year for Arcturus Therapeutics. Shares have dropped sharply after underwhelming trial news and legal scrutiny, leading to...

Coya Therapeutics has completed a $20 million follow-on equity offering. The company aims to strengthen its cash position and accelerate progress in the Phase 2 trial of COYA 302, its experimental ALS therapy. Investors are watching these milestones closely, as the FDA's recent acceptance of Coya's drug application and a triggered milestone payment bring new attention to the company’s clinical and financial strategy. See our latest analysis for Coya Therapeutics. After announcing the equity...

ETHZilla is drawing attention after unveiling a $15 million strategic partnership with Satschel, Inc., parent of Liquidity.io. This collaboration gives ETHZilla a 15% equity stake as well as exclusive rights within regulated digital asset markets. See our latest analysis for ETHZilla. Momentum has picked up again for ETHZilla after the Satschel investment, with the share price jumping 17.38% in just the last day and 7.32% over the past week, though recent news-fueled rallies come against the...

Earlier this week, Luminar Technologies announced that its lidar technology is now integrated into Volvo’s EX90 and is being included on platforms from Mercedes-Benz, NVIDIA, and Mobileye, while it also provided updates on its next-generation “Halo” chipset and production plans for late 2025 and early 2026. An interesting takeaway is that despite these prominent partnerships and advancements, the company revised its full-year 2025 guidance downward due to slower automotive ramp-up, winding...

Eightco Holdings (ORBS) is in the spotlight again after its move to adopt Worldcoin as a primary reserve asset and bring Dan Ives on board as chairman. This shake-up has sparked renewed interest and rapid price swings. See our latest analysis for Eightco Holdings. ORBS has seen one of the most dramatic runs among speculative stocks this year, with the 1-year total shareholder return at nearly 231%. Yet, this surge comes after years of heavy losses, a delisting, and repeated pivoting between...

Flux Power Holdings (FLUX) has regained compliance with Nasdaq’s listing rules after facing a potential delisting. This development is likely to boost investor confidence and renew interest in the company’s prospects. See our latest analysis for Flux Power Holdings. Regaining Nasdaq compliance comes after a dramatic surge in Flux Power Holdings’ share price, with a 30-day share price return of 85.5% and a striking year-to-date gain of 252.9%. That momentum has reignited interest, especially...

Picard Medical (PMI) shares dropped sharply after the company’s recent SEC filing revealed an expanded equity incentive plan. The filing increased authorized shares and added new types of stock awards, sparking fresh concerns over possible shareholder dilution. See our latest analysis for Picard Medical. The latest shakeup at Picard Medical comes on the heels of its recent IPO and the unveiling of new patents for its artificial heart technology. However, none of that cushioned the blow from...

Despite the fact that PubMatic, Inc. (NASDAQ:PUBM) stock rose 10% last week, insiders who sold US$319k worth of stock...

The recent 10% drop in Marten Transport, Ltd.'s ( NASDAQ:MRTN ) stock could come as a blow to insiders who purchased...

Key Insights LSB Industries' estimated fair value is US$12.94 based on 2 Stage Free Cash Flow to Equity LSB Industries...

While it may not be enough for some shareholders, we think it is good to see the AMC Networks Inc. ( NASDAQ:AMCX...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Key Insights The projected fair value for Lear is US$143 based on 2 Stage Free Cash Flow to Equity Lear is estimated to...

With a median price-to-earnings (or "P/E") ratio of close to 19x in the United States, you could be forgiven for...

Aptera Motors has officially transitioned to a Public Benefit Corporation. This move ties its governance to sustainability goals in solar electric vehicle development. The company also strengthened its Board by appointing two industry veterans. See our latest analysis for Aptera Motors. Aptera’s latest flurry of leadership changes, index inclusion, and new share filings has certainly kept it in the headlines, and the stock has responded in kind. After surging over 50% in the past week,...

Ready Capital (RC) shares dropped nearly 30% after the company reported quarterly results that did not meet expectations. This decline came as slower growth in net interest income and falling earnings per share have raised new questions about its long-term profitability. See our latest analysis for Ready Capital. After a steep 30% share price drop over the last month, Ready Capital's recent losses have only compounded a tough year. Its year-to-date share price return stands at -54.8%, with a...

Provident Bancorp (PVBC) reported a net profit margin of 20.2%, more than doubling from 9.6% the previous year and highlighting a significant improvement in profitability. Earnings growth for the past twelve months came in at 136.1%, far surpassing the company’s five-year average, though longer-term earnings have actually declined by an average of 8.2% per year. Looking ahead, consensus calls for earnings to decrease 3.8% annually over the next three years and for revenue to grow just 1.7%...

Thinking about whether to hold, buy, or move on from Burford Capital? You're not alone. The past year has been a wild ride, with the stock dropping 20.4%, and more recently, a dip of 13.3% over the last month alone. At first glance, those numbers might raise some eyebrows, but any seasoned investor will tell you that sometimes sell-offs create opportunity rather than signal real trouble. What's been driving these moves? Well, the legal finance sector has been under the spotlight, with growing...

Elme Communities (ELME) reported expanding losses, which have grown at an annual rate of 8.5% over the past five years. Revenue is projected to shrink significantly, declining 50.9% per year over the next three years. Profitability is not forecast in this period, and the company’s valuation metrics are stretched, with a price-to-sales ratio of 5.9x exceeding both peer and industry averages. With shares trading at $16.65, far above an estimated fair value of $1.36, and both major and minor...

MidWestOne Financial Group (MOFG) has turned a corner after a five-year period where earnings declined 30.9% per year, managing to swing into profitability in the latest year. Looking ahead, analysts expect the company’s earnings to grow 17.4% per year and revenue is forecast to climb 13.4% annually. Both metrics are anticipated to outpace the US market’s respective 15.5% and 10% average growth rates. With net profit margins now positive and fundamentals such as dividend attractiveness and...

ETHZilla Corporation recently completed a 1-for-10 stock split on October 20, 2025, and appointed John D. Kristoff as Senior Vice President, Corporate Communications and Investor Relations, reporting directly to Chairman and CEO McAndrew Rudisill. This combination of a share structure change and the creation of a high-level communications and investor relations role highlights ETHZilla's focus on expanding accessibility and strengthening its engagement with both investors and the...

Earlier this week, Alector and its partner GSK announced that latozinemab failed to meet safety and efficacy criteria in a Phase 3 clinical trial for frontotemporal dementia due to GRN gene mutations, leading to the discontinuation of related studies and a workforce reduction of approximately 49%. This setback not only impacts Alector's core pipeline but also coincides with the resignation of its President and Head of R&D, highlighting significant changes in the company's direction. We'll...